Stay updated on Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial
Sign up to get notified when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.

Latest updates to the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page footer now displays Revision: v3.4.2, replacing v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing v3.4.0. This appears to be a minor administrative update with no impact on the study information presented.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page now includes a glossary toggle and minor wording/case changes in metadata labels (e.g., 'Last Update...' and 'No FEAR Act Data') along with a new revision label. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check39 days agoChange DetectedPage shows a new revision label: Revision: v3.3.4 replacing v3.3.3, with no changes to the study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedAdded a dedicated Locations section listing Seongnam-si and updated the page to Revision v3.3.3; removed the HHS Vulnerability Disclosure reference and the Seongnam-si Locations reference.SummaryDifference0.2%

- Check89 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunogenicity in Kids 6-35m: NBP607-QIV vs Agrippal Clinical Trial page.